﻿<?xml version="1.0" encoding="utf-8"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:n="http://www.google.com/schemas/sitemap-news/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd"><url><loc>https://www.indianpharmapost.com/spl-infusion-commences-commercial-production-of-new-iv-fluid-infusion-plant-17751</loc><lastmod>2025-09-09T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/ichnos-glenmark-innovation-receives-upfront-payment-of-700-million-from-abbvie-17752</loc><lastmod>2025-09-09T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/alcon-india-launches-unity-vcscs-for-vitreoretinal-and-cataract-surgery-17753</loc><lastmod>2025-09-09T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/congruence-gets-32-million-financing-to-advance-genetic-obesity-candidate-drug-17754</loc><lastmod>2025-09-09T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/biocytogen-and-merck-to-advance-antibody-conjugated-lipid-based-delivery-solutions-17755</loc><lastmod>2025-09-09T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/gilead-sciences-breaks-ground-on-new-manufacturing-and-technical-development-site-in-us-17756</loc><lastmod>2025-09-09T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/mrm-health-raises-55-million-series-b-to-advance-microbiome-based-biotherapeutic-product-pipeline-17757</loc><lastmod>2025-09-09T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url><url><loc>https://www.indianpharmapost.com/fda-grants-fast-track-designation-for-tevas-emrusolmin-17758</loc><lastmod>2025-09-09T00:00:00+05:30</lastmod><changefreq>always</changefreq><priority>0.9</priority></url>    
</urlset>